ArticleCureus2025
From Common Symptom to Critical Diagnosis: Vertigo as a Clue to Thrombotic Thrombocytopenic Purpura.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic thrombocytopenic purpura is a hematologic disease with a high mortality rate that affects multiple organ systems. It is caused by a deficiency of a metalloprotease known as the ADAMTS-13 enzyme. Patients can present with fever, hemolytic anemia, thrombocytopenia, kidney injury, and neurological symptoms. Here we present a case of a female with TTP who was initially diagnosed with benign paroxysmal positional vertigo (BPPV). Her initial symptoms were vertigo, blurry vision, and gait imbalance, which were accompanied by elevated total bilirubin, acute kidney injury, thrombocytopenia, and normal hemoglobin. When the patient followed up in her primary care clinic, she was found to have worsening renal function, hemolytic anemia, and severe thrombocytopenia. She was subsequently diagnosed with TTP and referred to the emergency department (ED) where she received emergent treatment with therapeutic plasma exchange (TPE) and later rituximab. This case stresses the importance of considering TTP in patients presenting with symptoms and laboratory values suggestive of the disease, even when anemia is not present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.